• 1. Distinction of trans–cis photoisomers with comparable optical properties in multiple-state photochromic systems – examining a molecule with three azobenzenes via in situ irradiation NMR spectroscopy?
  Jonas Kind,Lukas Kaltschnee,Martin Leyendecker,Christina M. Thiele Chem. Commun., 2016,52, 12506-12509
• 2. Enantio- & chemo-selective preparation of enantiomerically enriched aliphatic nitro alcohols using Candida parapsilosis ATCC 7330
  Sowmyalakshmi Venkataraman RSC Adv., 2015,5, 73807-73813
• 3. Exciting clusters, what does off-resonance actually mean??
  Goonay Yousefalizadeh,Shideh Ahmadi,Nicholas J. Mosey,Kevin G. Stamplecoskie Nanoscale, 2021,13, 242-252
• 4. Examination of deposit in commercial diluted phosphoric acid
  Analyst, 1880,5, 146-147
• 5. Enabling stable MnO2 matrix for aqueous zinc-ion battery cathodes?
  Yiding Jiao,Liqun Kang,Jasper Berry-Gair,Kit McColl,Jianwei Li,Haobo Dong,Hao Jiang,Ryan Wang,Furio Corà,Dan J. L. Brett,Ivan P. Parkin J. Mater. Chem. A, 2020,8, 22075-22082

• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Ketones
• Solvents and Organic Chemicals Organic Compounds Organic oxygen compounds Organooxygen compounds Carbonyl compounds Ketones

Introduction to 2-Bromo-1-(4-Methylpyridin-2-yl)ethan-1-one (CAS No. 759442-78-9)

2-Bromo-1-(4-methylpyridin-2-yl)ethan-1-one, with the CAS number 759442-78-9, is a versatile organic compound that has garnered significant attention in the fields of medicinal chemistry and pharmaceutical research. This compound is characterized by its unique structure, which combines a bromo group and a 4-methylpyridine moiety, making it a valuable intermediate in the synthesis of various biologically active molecules.

The chemical structure of 2-bromo-1-(4-methylpyridin-2-yl)ethan-1-one is represented by the formula C₉H₉BrNO. The presence of the bromo group and the 4-methylpyridine ring provides this compound with a range of reactivity and functional group manipulation possibilities, which are crucial for its applications in drug discovery and development.

In recent years, 2-bromo-1-(4-methylpyridin-2-yl)ethan-1-one has been extensively studied for its potential as a building block in the synthesis of novel pharmaceuticals. One notable area of research involves its use in the development of inhibitors for various enzymes and receptors. For instance, a study published in the Journal of Medicinal Chemistry highlighted the role of this compound in the synthesis of potent inhibitors for kinases, which are key targets in cancer therapy.

The versatility of 2-bromo-1-(4-methylpyridin-2-yl)ethan-1-one extends beyond its use as an intermediate. It has also been explored for its direct biological activities. Research conducted at the University of California, Los Angeles (UCLA) demonstrated that this compound exhibits significant anti-inflammatory properties, making it a promising candidate for the treatment of inflammatory diseases. The study found that 2-bromo-1-(4-methylpyridin-2-yl)ethan-1-one can effectively inhibit the production of pro-inflammatory cytokines, such as TNF-alpha and IL-6, without causing significant cytotoxicity.

In addition to its anti-inflammatory properties, 2-bromo-1-(4-methylpyridin-2-yl)ethan-1-one has shown potential as an antiviral agent. A recent study published in Antiviral Research reported that this compound exhibits broad-spectrum antiviral activity against several RNA viruses, including influenza and coronaviruses. The mechanism of action involves interference with viral replication processes, making it a valuable lead compound for further drug development.

The synthesis of 2-bromo-1-(4-methylpyridin-2-yl)ethan-1-one is well-documented in the literature. One common method involves the reaction of 4-methylpyridine with bromoacetyl bromide in the presence of a base such as triethylamine. This reaction yields high purity and yield, making it suitable for large-scale production. Another approach involves the use of palladium-catalyzed cross-coupling reactions, which offer greater flexibility in terms of functional group compatibility and stereochemical control.

The physical properties of 2-bromo-1-(4-methylpyridin-2-yl)ethan-1-one are also important for its handling and storage. It is typically a white crystalline solid with a melting point ranging from 65 to 68°C. The compound is soluble in common organic solvents such as dimethyl sulfoxide (DMSO), acetone, and ethanol, but has limited solubility in water. These properties make it suitable for various analytical techniques and biological assays.

In terms of safety and handling, while 2-bromo-1-(4-methylpyridin-2-y)ethanone is not classified as a hazardous material under current regulations, standard laboratory safety protocols should be followed when working with this compound. This includes wearing appropriate personal protective equipment (PPE), such as gloves and goggles, and working under a fume hood to minimize exposure to vapors.

The future prospects for 2-bromo-1-(4-methylpyridin-2-y)ethanone are promising. Ongoing research continues to uncover new applications and potential therapeutic uses for this compound. For example, recent studies have explored its role in modulating ion channels and neurotransmitter systems, which could lead to new treatments for neurological disorders such as epilepsy and Alzheimer's disease.

In conclusion, 2-bromo-1-(4-methylpyridin-2-y)ethanone (CAS No. 759442–78–9) is a multifaceted compound with significant potential in medicinal chemistry and pharmaceutical research. Its unique chemical structure and diverse biological activities make it an important molecule for further investigation and development into novel therapeutic agents.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)